Whole Body Counter Software Upgrade

The Food and Drug Administration intends to award a Purchase Order for Whole Body Software Upgrade. The requirements will be awarded using Simplified Acquisition Procedures in accordance with FAR 13.5. This is a combined synopsis/solicitation for commmercial items prepared in accordance with the format in FAR 12.6, as supplemented with additional information incuded in this notice. This announcement constitutes the solicitation: Proposals are being requested and a written solicitation will not be issued. The solicitation number is FDA-SOL-08-00926. This solicitation is issued as Request for Quote (RFQ). The associated North American Industry Classification System (NAICS) is 334519. Contract Type: Commercial Item-Firm Fixed Price. All responsible sources may submit a quote whIch shall be considered. The Food and Drug Administration is soliciting the following item: 1. Abacos 2000 WBC Software 1ea 2. G2K Basic spec, multi input software 1ea 3. G2K Gamma analysis software 1ea 4. G2K QA Software 5. Universal DB2 Database, single user 6. Install - Installation & set up of electronics on-site 1ea 7. CONSULT - Abacos 2K WBC Counter configuration set up and familiarization on-site and trainer expenses 8. POINT - Return of customer's PC to load software. FOB: Shipping Point - Origin. Company must be registered in Central Contractor Registration (CCR) before an award could be made to them. If company is not registered in CCR, they may do so by going to CCR web site at http://www.ccr.gov. The provision at FAR 52.212-1 Instructions to Offerors-Commercial Items applies to this solicitation. The following addenda have been attached to this provision: None. The provision at FAR 52.212-2 Evaluation-Commercial Item is applicable to this solicitation. The specific evaluation criteria to be included in paragraph (1) of that provision are as follows: (i) Technical capability of the items offered to meet the Government requirement. (ii) Price. The Government will award a Purchase Order resulting from this solicitation to the responsible offeror whose offer conforming to the solicitation will be the most advantageous to the Government, price and other technical factors considered. The Government is not responsible fo locating or securing any information, which is not identified in the proposal. To ensure information is available, vendors must furnish as part of their proposal all descriptive materials necessary for the Government to determine whether product meets the technical requirements. The Government reserves the right to make an award without discussions. The provision at FAR 52.212-3, Offeror Representation and Certification-Commercial Items, applies to this acquisition. The clause at FAR 52.212-4, Contract Terms and Conditions-Commercial applies to this acquisition. The clause at FAR 52.212-5, Contract Terms and Conditions Required to Implement Statutes of Executive Orders-Commercial Items applies to this acquisition. The following additional FAR clauses cited in this clause are applicable: 52.222-3; 52.222-19; 52.222-21; 52.222-26; 52.222-36; 52.225-1; 52.232-13 and 52.232-34. Clauses and provisions are incorporated by reference and apply to this acquisition. Clauses and provisions can be obtain at http://www.acquisition.gov. Offers are due in person, by postal mail, by email or fax on or before September 17, 2008, by 15:00 Eastern Daylight Saving Time. Local Prevailing Time in Atlanta, GA at Food and Drug Administration OSS/PB, Attn: Roy E. Mutch, 60 8th Street, NE, Atlanta, GA 30309. For information regarding this solicitation, please contact Roy E. Mutch @ (404) 253-1258, or email roy.mutch@fda.hhs.gov.